During the past decade, King Abdullah International Medical Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Abdullah International Medical Research Center" #1 sponsor was "King Abdullah International Medical Research Center" with 3 trials, followed by "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Hikma Pharmaceuticals LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Abdullah International Medical Research Center" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "King Abdullah International Medical Research Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "King Abdullah International Medical Research Center" are "Ulcerative Colitis" (2 trials), "Anxiety" (1 trials), "Arteriovenous Fistula" (1 trials), "Cardiovascular Disease" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "King Abdullah International Medical Research Center" in a lesser frequency.

Most popular intervention types in "King Abdullah International Medical Research Center" are "Drug" (6 trials), "Other" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mitapivat" (2 trials), "Placebo Matching Mitapivat" (2 trials), "Combination of Lopinavir /Ritonavir and Interferon beta-1b" (1 trials) and "Evidence-based practices" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Abdullah International Medical Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "King Abdullah International Medical Research Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in King Abdullah International Medical Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in King Abdullah International Medical Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".